[BMJ] Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome

Closed

zugarramurdi57 Post time 2024-5-1 01:44:13 | Show all posts |Read mode

Reward10points

journal：European Journal of Hospital Pharmacy

Authors：Gerda Ratzinger-Stoeger; Maria Anzengruber; Katharina Skoll; Diana-Alexandra Ertl; Gabriele Hartmann; Franz Gabor

Published date：--

DOI：10.1136/ejhpharm-2023-003853

PDF link：https://syndication.highwire.org ... jhpharm-2023-003853

Article link：http://dx.doi.org/10.1136/ejhpharm-2023-003853

Article Source：BMJ。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

zugarramurdi57 Lv.4

Senior Member

post
reply
points
8775

[BMJ] Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome Copy

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[BMJ] Formulation and characterisation of metyrapone suppositories for the first effective long-term use in an infant with McCune-Albright syndrome-related Cushing syndrome